Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  HIV Infection

  Free Subscription


15.04.2019

1 AIDS
1 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
3 Antivir Ther
2 BMJ
11 Clin Infect Dis
1 Drugs
1 HIV Med
17 J Acquir Immune Defic Syndr
2 J Infect Dis
1 J Virol
3 JAMA
1 Lancet
8 Lancet HIV
1 Lancet Public Health
2 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Nature
2 PLoS Comput Biol
2 PLoS Med
14 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. SAMET JH, Blokhina E, Cheng DM, Walley AY, et al
    A strengths-based case management intervention to link HIV-positive PWID in Russia to HIV care - results from a randomized controlled trial.
    AIDS. 2019 Apr 5. doi: 10.1097/QAD.0000000000002230.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  2. MCKELLAR MS, Kuchibhatla MN, Oursler K, Crystal Ph D S, et al
    Race differences in change in physical functioning in older male veterans with HIV.
    AIDS Res Hum Retroviruses. 2019 Apr 9. doi: 10.1089/AID.2018.0296.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  3. HATTORI SI, Hayashi H, Bulut H, Rao KV, et al
    Halogen bond interactions of novel HIV-1 protease inhibitors (PI)(GRL-001-15 and GRL-003-15) with the flap of protease are critical for their potent activity against wild-type and multi-PI-resistant HIV-1 variants.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02635.
    PubMed     Text format     Abstract available


    Antivir Ther

  4. ZONDAGH J, Basson AE, Achilonu I, Morris L, et al
    Drug susceptibility and replication capacity of a rare HIV-1 subtype C protease hinge region variant.
    Antivir Ther. 2019 Apr 8. doi: 10.3851/IMP3308.
    PubMed     Text format     Abstract available

  5. ARMENIA D, Di Carlo D, Lepri AC, Calcagno A, et al
    Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen.
    Antivir Ther. 2019 Apr 12. doi: 10.3851/IMP3309.
    PubMed     Text format     Abstract available

  6. HUDSON FP, Mulenga L, Westfall AO, Warrier R, et al
    Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka Zambia.
    Antivir Ther. 2019 Apr 12. doi: 10.3851/IMP3299.
    PubMed     Text format     Abstract available


    BMJ

  7. GOGA A, Singh Y, Jackson D, Pillay Y, et al
    Is elimination of vertical transmission of HIV in high prevalence settings achievable?
    BMJ. 2019;364:l687.
    PubMed     Text format    

  8. GOGA A, Singh Y, Jackson D, Mukungunugwa S, et al
    How are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV?
    BMJ. 2019;364:l660.
    PubMed     Text format    


    Clin Infect Dis

  9. MCMORROW ML, Tempia S, Walaza S, Treurnicht FK, et al
    The impact of HIV exposure on respiratory syncytial virus-associated severe respiratory illness in South African infants, 2011-2016.
    Clin Infect Dis. 2019 Apr 9. pii: 5432318. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. HONG H, Dowdy DW, Dooley KE, Francis HW, et al
    Aminoglycoside-Induced Hearing Loss Among Patients Being Treated for Drug-Resistant Tuberculosis in South Africa: A Prediction Model.
    Clin Infect Dis. 2019 Apr 9. pii: 5432319. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. KOBAYASHI M, Bigogo G, Kim L, Mogeni OD, et al
    Impact of 10-valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns among Children aged <5 Years and Adults with HIV Infection, Kenya 2009-2013.
    Clin Infect Dis. 2019 Apr 9. pii: 5432315. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. UGARTE-GIL C, Alisjahbana B, Ronacher K, Riza AL, et al
    Diabetes mellitus among pulmonary tuberculosis patients from four TB-endemic countries: the TANDEM study.
    Clin Infect Dis. 2019 Apr 8. pii: 5431210. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. MARTIN TCS, Chaillon A, Graves SK, Lin T, et al
    Genetic network analysis to assess the risk of HIV transmission among MSM seeking partners on the Internet.
    Clin Infect Dis. 2019 Apr 6. pii: 5429566. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. BYRD KK, Hou JG, Bush T, Hazen R, et al
    Adherence and viral suppression among participants of the Patient-centered HIV Care Model project-a collaboration between community-based pharmacists and HIV clinical providers.
    Clin Infect Dis. 2019 Apr 6. pii: 5429568. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. DIETRICH LG, Barcelo C, Thorball CW, Ryom L, et al
    Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate.
    Clin Infect Dis. 2019 Apr 6. pii: 5429565. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. COTTRELL ML, Prince HMA, Schauer AP, Sykes C, et al
    Decreased tenofovir diphosphate concentrations in a transgender female cohort: Implications for HIV pre-exposure prophylaxis (PrEP).
    Clin Infect Dis. 2019 Apr 9. pii: 5432320. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. NEWMAN DR, Rahman MM, Brantley A, Peterman TA, et al
    Rates of new HIV diagnoses after Reported STI, Women in Louisiana 2000-2015: Implications for HIV Prevention.
    Clin Infect Dis. 2019 Apr 12. pii: 5446594. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. BUTT AA, Yan P, Aslam S, Shaikh OS, et al
    Hepatitis C Virus Treatment with Directly Acting Agents Reduces the Risk of Incident Diabetes - Results from ERCHIVES.
    Clin Infect Dis. 2019 Apr 12. pii: 5448895. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. KOVARI H, Calmy A, Doco-Lecompte T, Nkoulou R, et al
    Antiretroviral Drugs Associated with Subclinical Coronary Artery Disease in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2019 Apr 8. pii: 5432300. doi: 10.1093.
    PubMed     Text format     Abstract available


    Drugs

  20. GIBAS KM, van den Berg P, Powell VE, Krakower DS, et al
    Drug Resistance During HIV Pre-Exposure Prophylaxis.
    Drugs. 2019 Apr 8. pii: 10.1007/s40265-019-01108.
    PubMed     Text format     Abstract available


    HIV Med

  21. BOCK P, Nel K, Fatti G, Sloot R, et al
    Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (Po
    HIV Med. 2019 Apr 8. doi: 10.1111/hiv.12729.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  22. LE BERRE AP, Fama R, Sassoon SA, Pfefferbaum A, et al
    Cognitive and Motor Impairment Severity Related to Signs of Subclinical Wernicke's Encephalopathy in HIV Infection.
    J Acquir Immune Defic Syndr. 2019 Apr 3. doi: 10.1097/QAI.0000000000002043.
    PubMed     Text format     Abstract available

  23. CALABRESE SK, Willie TC, Galvao RW, Tekeste M, et al
    Current US Guidelines for Prescribing HIV Pre-Exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002042.
    PubMed     Text format     Abstract available

  24. JANET J M, Mi-Suk KD, Kimberly A K, Ifeoma U, et al
    Adherence to PrEP among young men who have sex with men participating in a sexual health services demonstration project in Alameda County, California.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002051.
    PubMed     Text format     Abstract available

  25. WILLIAMS EC, McGinnis KA, Tate JP, Matson TE, et al
    HIV Disease Severity is Sensitive to Temporal Changes in Alcohol Use: A National Study of VA Patients with HIV.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002049.
    PubMed     Text format     Abstract available


  26. Transmission Networks of HCV Genotype 1a Enriched With Pre-existing Polymorphism Q80K Among HIV-Infected Patients With Acute Hepatitis C in Poland: Erratum.
    J Acquir Immune Defic Syndr. 2019;81:e27.
    PubMed     Text format    

  27. CAI J, Sebastiani G
    HIV, Elevated Transaminases, Fatty Liver: The Perfect Storm?
    J Acquir Immune Defic Syndr. 2019;81:e23-e25.
    PubMed     Text format    

  28. BARNELL GM, Merchant M, Lam JO, Silverberg MJ, et al
    Early outcomes of a high-resolution anoscopy-based anal cancer screening program among people with HIV enrolled in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2019 Mar 29. doi: 10.1097/QAI.0000000000002040.
    PubMed     Text format     Abstract available

  29. NYAGAH LM, Young PW, Kim AA, Wamicwe J, et al
    HIV-Related Deaths in Nairobi, Kenya: Results From a HIV Mortuary Surveillance Study, 2015.
    J Acquir Immune Defic Syndr. 2019;81:18-23.
    PubMed     Text format     Abstract available

  30. FEARON E, Phillips A, Mtetwa S, Chabata ST, et al
    How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis.
    J Acquir Immune Defic Syndr. 2019;81:24-35.
    PubMed     Text format     Abstract available

  31. MORAKA NO, Moyo S, Mayondi G, Leidner J, et al
    Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.
    J Acquir Immune Defic Syndr. 2019;81:118-124.
    PubMed     Text format     Abstract available

  32. SERETI I, Gulick RM, Krishnan S, Migueles SA, et al
    ART in HIV-positive persons with low pre-treatment viremia: results from the START trial.
    J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002052.
    PubMed     Text format     Abstract available

  33. KAIDA A, Kabakyenga J, Bwana M, Bajunirwe F, et al
    High incidence of intended partner pregnancy among men living with HIV in rural Uganda: Implications for safer conception services.
    J Acquir Immune Defic Syndr. 2019 Apr 8. doi: 10.1097/QAI.0000000000002053.
    PubMed     Text format     Abstract available

  34. DAVEY DJ, Wall KM, Serrao C, Prins M, et al
    HIV positivity and referral to treatment following index testing of partners and children of HIV-infected patients in public sector facilities in South Africa.
    J Acquir Immune Defic Syndr. 2019 Apr 4. doi: 10.1097/QAI.0000000000002048.
    PubMed     Text format     Abstract available

  35. MCCREE DH, Williams AM, Chesson HW, Beer L, et al
    Changes in Disparities in Estimated HIV Incidence Rates Among Black, Hispanic/Latino, and White Men Who Have Sex With Men (MSM) in the United States, 2010-2015.
    J Acquir Immune Defic Syndr. 2019;81:57-62.
    PubMed     Text format     Abstract available

  36. VIDOT DC, Manuzak JA, Klatt NR, Pallikkuth S, et al
    Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users with Treated HIV Infection.
    J Acquir Immune Defic Syndr. 2019 Apr 3. doi: 10.1097/QAI.0000000000002046.
    PubMed     Text format     Abstract available

  37. HAMMOUD MA, Vaccher S, Jin F, Bourne A, et al
    HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia and factors associated with the non-use of PrEP among eligible men: Results from a prospective cohort study.
    J Acquir Immune Defic Syndr. 2019 Apr 4. doi: 10.1097/QAI.0000000000002047.
    PubMed     Text format     Abstract available

  38. NYAMATHI AN, Shin SS, Sinha S, Carpenter CL, et al
    Sustained Effect of a Community-based Behavioral and Nutrition Intervention on HIV-related Outcomes among Women living with HIV in Rural India: A Quasi-experimental Trial.
    J Acquir Immune Defic Syndr. 2019 Apr 4. doi: 10.1097/QAI.0000000000002044.
    PubMed     Text format     Abstract available


    J Infect Dis

  39. VERRALL AJ, Schneider M, Alisjahbana B, Apriani L, et al
    Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses.
    J Infect Dis. 2019 Apr 8. pii: 5431213. doi: 10.1093.
    PubMed     Text format     Abstract available

  40. KENYON C, Buyze J, Spiteri G, Cole MJ, et al
    Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.
    J Infect Dis. 2019 Apr 8. pii: 5430759. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  41. LI G, Zhang Z, Reszka-Blanco N, Li F, et al
    Specific activation of HIV-1 by a bromodomain inhibitor from monocytic cells in humanized mice under ART in vivo.
    J Virol. 2019 Apr 10. pii: JVI.00233-19. doi: 10.1128/JVI.00233.
    PubMed     Text format     Abstract available


    JAMA

  42. ABBASI J
    HIV Remission After Hematopoietic Stem Cell Transplant.
    JAMA. 2019;321:1343.
    PubMed     Text format    

  43. GANDHI M, Spinelli MA, Mayer KH
    Addressing the Sexually Transmitted Infection and HIV Syndemic.
    JAMA. 2019;321:1356-1358.
    PubMed     Text format    

  44. TRAEGER MW, Cornelisse VJ, Asselin J, Price B, et al
    Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    JAMA. 2019;321:1380-1390.
    PubMed     Text format     Abstract available


    Lancet

  45. FRASER B
    Providing care for trans women with HIV/AIDS in Peru.
    Lancet. 2019;393:1399-1400.
    PubMed     Text format    


    Lancet HIV

  46. OLDENBURG CE
    Integrated HIV prevention and care for key populations.
    Lancet HIV. 2019 Apr 2. pii: S2352-3018(19)30042.
    PubMed     Text format    

  47. CAPOFERRI AA, Bale MJ, Simonetti FR, Kearney MF, et al
    Phylogenetic inference for the study of within-host HIV-1 dynamics and persistence on antiretroviral therapy.
    Lancet HIV. 2019 Apr 5. pii: S2352-3018(19)30051.
    PubMed     Text format     Abstract available

  48. SOLOMON SS, Solomon S, McFall AM, Srikrishnan AK, et al
    Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial.
    Lancet HIV. 2019 Apr 2. pii: S2352-3018(19)30034.
    PubMed     Text format     Abstract available


  49. Correction to Lancet HIV 2018; 6: e93-104.
    Lancet HIV. 2019 Apr 2. pii: S2352-3018(19)30106.
    PubMed     Text format    

  50. HAYWARD P
    Highlights of the 26th CROI 2019.
    Lancet HIV. 2019;6:e218.
    PubMed     Text format    

  51. HOLT E
    Disputed figures do not hide Russia's HIV epidemic.
    Lancet HIV. 2019;6:e216-e217.
    PubMed     Text format    


  52. Correction to Lancet HIV 2019; 6: e173-81.
    Lancet HIV. 2019 Apr 3. pii: S2352-3018(19)30108.
    PubMed     Text format    


  53. Correction to Lancet HIV 2019; 6: e230-39.
    Lancet HIV. 2019 Apr 3. pii: S2352-3018(19)30107.
    PubMed     Text format    


    Lancet Public Health

  54. SHOKOOHI M, Rahimi-Movaghar A, Noroozi A, Karamouzian M, et al
    A public health approach to alcohol use and its related harms in Iran.
    Lancet Public Health. 2019;4:e175-e176.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  55. JOHNSON JONES ML, Chapin-Bardales J, Bizune D, Papp JR, et al
    Extragenital Chlamydia and Gonorrhea Among Community Venue-Attending Men Who Have Sex with Men - Five Cities, United States, 2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:321-325.
    PubMed     Text format     Abstract available

  56. BRENNAN J, Moore K, Sizemore L, Mathieson SA, et al
    Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection - Tennessee, 2018.
    MMWR Morb Mortal Wkly Rep. 2019;68:328-329.
    PubMed     Text format    


    N Engl J Med

  57. WOJCIECHOWSKI D, Gandhi RT, Rosales IA
    Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease.
    N Engl J Med. 2019;380:1464-1472.
    PubMed     Text format    


    Nature

  58. HENRICH TJ
    Second example reported of a stem-cell transplant in the clinic leading to HIV remission.
    Nature. 2019;568:175-176.
    PubMed     Text format    

  59. LU M, Ma X, Castillo-Menendez LR, Gorman J, et al
    Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET.
    Nature. 2019 Apr 10. pii: 10.1038/s41586-019-1101.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  60. ROSENBLOOM DIS, Bacchetti P, Stone M, Deng X, et al
    Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.
    PLoS Comput Biol. 2019;15:e1006849.
    PubMed     Text format     Abstract available

  61. CONTI S, Karplus M
    Estimation of the breadth of CD4bs targeting HIV antibodies by molecular modeling and machine learning.
    PLoS Comput Biol. 2019;15:e1006954.
    PubMed     Text format     Abstract available


    PLoS Med

  62. KAWASAKI M, Echiverri C, Raymond L, Cadena E, et al
    Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    PLoS Med. 2019;16:e1002780.
    PubMed     Text format     Abstract available

  63. MINERS A, Nadarzynski T, Witzel C, Phillips AN, et al
    Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment.
    PLoS Med. 2019;16:e1002779.
    PubMed     Text format     Abstract available


    PLoS One

  64. BLANKLEY S, Gashu T, Ahmad B, Belaye AK, et al
    Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe.
    PLoS One. 2019;14:e0214739.
    PubMed     Text format     Abstract available

  65. EAKLE R, Bothma R, Bourne A, Gumede S, et al
    "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    PLoS One. 2019;14:e0212271.
    PubMed     Text format     Abstract available

  66. GOODELL AJ, Shete PB, Vreman R, McCabe D, et al
    Outlook for tuberculosis elimination in California: An individual-based stochastic model.
    PLoS One. 2019;14:e0214532.
    PubMed     Text format     Abstract available

  67. JAIR K, McCann CD, Reed H, Castel AD, et al
    Validation of publicly-available software used in analyzing NGS data for HIV-1 drug resistance mutations and transmission networks in a Washington, DC, Cohort.
    PLoS One. 2019;14:e0214820.
    PubMed     Text format     Abstract available

  68. MIRZAZADEH A, Noori A, Shengelia N, Chikovani I, et al
    HIV continues to spread among men who have sex with men in Georgia; time for action.
    PLoS One. 2019;14:e0214785.
    PubMed     Text format     Abstract available

  69. MESA KA, Yu B, Wrin T, Petropoulos CJ, et al
    Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.
    PLoS One. 2019;14:e0213409.
    PubMed     Text format     Abstract available

  70. WULANDARI LPL, Ruddick A, Guy R, Kaldor J, et al
    "Self-testing sounds more private, rather than going to the clinic and everybody will find out": Facilitators and barriers regarding HIV testing among men who purchase sex in Bali, Indonesia.
    PLoS One. 2019;14:e0214987.
    PubMed     Text format     Abstract available

  71. SHIFERAW E, Tadilo W, Melkie I, Shiferaw M, et al
    Sero-prevalence and trends of transfusion-transmissible infections among blood donors at Bahir Dar district blood bank, northwest Ethiopia: A four year retrospective study.
    PLoS One. 2019;14:e0214755.
    PubMed     Text format     Abstract available

  72. VENABLES E, Ndlovu Z, Munyaradzi D, Martinez-Perez G, et al
    Patient and health-care worker experiences of an HIV viral load intervention using SMS: A qualitative study.
    PLoS One. 2019;14:e0215236.
    PubMed     Text format     Abstract available

  73. ATEGEKA J, Wasswa R, Olwoch P, Kakuru A, et al
    The prevalence of histologic acute chorioamnionitis among HIV infected pregnant women in Uganda and its association with adverse birth outcomes.
    PLoS One. 2019;14:e0215058.
    PubMed     Text format     Abstract available

  74. RUTAIHWA LK, Sasamalo M, Jaleco A, Hella J, et al
    Insights into the genetic diversity of Mycobacterium tuberculosis in Tanzania.
    PLoS One. 2019;14:e0206334.
    PubMed     Text format     Abstract available

  75. ANOUBISSI JD, Gabriel EL, Kengne Nde C, Fokam J, et al
    Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis.
    PLoS One. 2019;14:e0208963.
    PubMed     Text format     Abstract available

  76. CHEN B, Alam M
    STRETCHing HIV treatment: A replication study of task shifting in South Africa.
    PLoS One. 2019;14:e0206677.
    PubMed     Text format     Abstract available

  77. CUPO A, Cruz Portillo VM, Gelfand P, Yasmeen A, et al
    Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells.
    PLoS One. 2019;14:e0215106.
    PubMed     Text format     Abstract available


    PLoS Pathog

  78. HENSLEY-MCBAIN T, Wu MC, Manuzak JA, Cheu RK, et al
    Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection.
    PLoS Pathog. 2019;15:e1007672.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  79. VAN DUYNE R, Kuo LS, Pham P, Fujii K, et al
    Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle.
    Proc Natl Acad Sci U S A. 2019 Apr 11. pii: 1820333116.
    PubMed     Text format     Abstract available


    Virology

  80. BUFFONE C, Kutzner J, Opp S, Martinez-Lopez A, et al
    The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.
    Virology. 2019;531:260-268.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: